1.Gorman, C, Park, A & Dell, K (2004) Health: the fires within. Time (23 February, USA edition) 163(8), 38–45.
2.Hotamisligil, GS (2006) Inflammation and metabolic disorders. Nature 444, 860–867.
3.Bastard, JP, Maachi, M, Lagathu, C et al. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17, 4–12.
4.Festa, A, D'Agostino, R Jr, Williams, K et al. . (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25, 1407–1415.
5.Park, HS, Park, JY & Yu, R (2005) Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69, 29–35.
6.Bulló, M, García-Lorda, P, Megias, I et al. (2003) Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 11, 525–531.
7.Hermsdorff, HH, Zulet, MA, Puchau, B et al. (2011) Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation 34, 161–170.
8.Lapice, E, Maione, S, Patti, L et al. (2009) Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy nonobese people. Diabetes Care 32, 1734–1736.
9.Wajchenberg, BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21, 697–738.
10.Wärnberg, J, Nova, E, Romeo, J et al. (2007) Lifestyle-related determinants of inflammation in adolescence. Br J Nutr 98, Suppl. 1, S116–S120.
11.Quijada, Z, Paoli, M, Zerpa, Y et al. (2008) The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Pediatr Diabetes 9, 464–471.
12.Weiss, R, Dziura, J, Burgert, TS et al. (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350, 2362–2374.
13.Halle, M, Korsten-Reck, U, Wolfarth, B et al. (2004) Low-grade systemic inflammation in overweight children: impact of physical fitness. Exerc Immunol Rev 10, 66–74.
14.Reinehr, T, Stoffel-Wagner, B, Roth, CL et al. (2005) High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children. Metabolism 54, 1155–1161.
15.Gupta, A, Ten, S & Anhalt, H (2005) Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children. J Pediatr Endocrinol Metab 18, 75–82.
16.Aeberli, I, Molinari, L, Spinas, G et al. (2006) Dietary intakes of fat and antioxidant vitamins are predictors of subclinical inflammation in overweight Swiss children. Am J Clin Nutr 84, 748–755.
17.Giordano, P, Del Vecchio, GC, Cecinati, V et al. (2011) Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. Eur J Pediatr 170, 845–850.
18.Gøbel, RJ, Jensen, SM, Frøkiaer, H et al. (2012) Obesity, inflammation and metabolic syndrome in Danish adolescents. Acta Paediatr 101(2), 192–200.
19.Wärnberg, J, Nova, E, Moreno, LA et al. (2006) Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr 84, 505–512.
20.Martínez-Gómez, D, Eisenmann, JC, Wärnberg, JA et al. (2010) Associations of physical activity, fitness and fatness with low-grade inflammation in adolescents. The AFINOS study. Int J Obes (London) 34, 1501–1507.
21.Ruiz, JR, Ortega, FB, Warnberg, J et al. (2007) Associations of low-grade inflammation with physical activity, fitness and fatness in prepubertal children; the European Youth Heart Study. Int J Obes (Lond) 31, 1545–1551.
22.Romeo, J, Martínez-Gómez, D, Díaz, LE et al. (2011) Changes in cardiometabolic risk factors, appetite-controlling hormones and cytokines after a treatment programme in overweight adolescents: preliminary findings from the EVASYON study. Pediatric Diabetes 12, 372–380.
23.Martí, A, Marcos, A & Martínez, JA (2001) Obesity and immune function relationships. Obes Rev 2, 131–140.
24.Sheridan, PA, Paich, HA, Handy, J et al. (2011) Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond), doi: 10.1038/ijo.2011.208. (Epublication ahead of print version).
25.Caspar-Bauguil, S, Cousin, B, Galinier, A et al. (2005) Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett 579, 3487–3492.
26.Saely, CH, Geiger, K & Drexel, H (2010) Brown versus white adipose tissue: a mini-review. Gerontology 58(1), 15–23.
27.Poglio, S, de Toni-Costes, F, Arnaud, E et al. (2010) Adipose tissue as a dedicated reservoir of functional mast cell progenitors. Stem Cells 28, 2065–2072.
28.Weisberg, SP, McCann, D, Desai, M et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796–1808.
29.Lumeng, CN, Bodzin, JL & Saltiel, AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117, 175–184.
30.Odegaard, JI, Ricardo-González, RR, Goforth, MH et al. (2007) Macrophage-specific PPAR-gamma controls alternative activation and improves insulin resistance. Nature 447, 1116–1120.
31.Trayhurn, P & Wood, IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347–355.
32.Tilg, H & Moschen, AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature 6, 772–783.
33.Koerner, A, Kratzsch, J & Kiess, W (2005) Adipocytokines: leptin – the classical, resistin – the controversial, adiponectin – the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19, 525–546.
34.Virtue, S & Vidal-Puig, A (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome – an allostatic perspective. Biochim Biophys Acta 1801, 338–349.
35.Pietiläinen, KH, Róg, T, Seppänen-Laakso, T et al. (2011) Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 9, e1000623.
36.Stryjecki, C & Mutch, DM (2011) Fatty acid-gene interactions, adipokines and obesity. Eur J Clin Nutr 65, 285–297.
37.Suganami, T, Tanimoto-Koyama, K, Nishida, J et al. (2007) Role of the toll-like receptor 4/NF-kappa B pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27, 84–91.
38.Fernández-Real, JM, Vendrell, J & Ricart, W (2005) Circulating adiponectin and plasma fatty acid profile. Clin Chem 51, 603–609.
39.Pérez de Heredia, F, Sánchez, J, Priego, T et al. (2009) Adiponectin is associated with serum and adipose tissue fatty acid composition in rats. J Endocrinol Invest 32, 659–665.
40.Coll, T, Barroso, E, Álvarez-Guardia, D et al. (2010) The role of peroxisome proliferator-activated receptor beta/delta on the inflammatory basis of metabolic disease. PPAR Res, pii, 368467.
41.Fessler, MB, Rudel, LL & Brown, JM (2009) Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol 20, 379–385.
42.Grunfeld, C & Feingold, KR (1991) The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 3, 143–158.
43.Mei, M, Zhao, L, Li, Q et al. (2011) Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice. Lipids Health Dis 10, 1–10 (Epublication ahead of print version).
44.Gregor, MF & Hotamisligil, GS (2007) Thematic review series: Adipocyte biology. adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res 48, 1905–1914.
45.Trayhurn, P, Pérez de Heredia, F, Wang, B et al. (2010) Hypoxia – role in adipocyte function and dysfunction. In Novel Insight into Adipose Cell Functions, pp. 45–60 [Clément, K, Spiegelman, BM and Christen, Y, editors]. Berlin, Heidelberg: Springer-Verlag.
46.Pérez de Heredia, F, Wood, IS & Trayhurn, P (2010) Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, MCT4) expression in human adipocytes. Pflüg Arch – Eur J Physiol 459, 509–518.
47.Samuvel, DJ, Sundararaj, KP, Nareika, A et al. (2009) Lactate boosts TLR4 signaling and NF-ΚB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. J Immunol 182, 2476–2484.
48.Pérez de Heredia, F, Wood, IS & Trayhurn, P (2010) Lactate enhances the inflammatory response in human preadipocytes in vitro. Obes Rev 11, Suppl. 1, 122 (Abstract).
49.Halberg, N, Khan, T, Trujillo, ME et al. (2009) Hypoxia-inducible factor 1α induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 29, 4467–4483.
50.Cancello, R, Tordjman, J, Poitou, C et al. (2006) Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55, 1554–1561.
51.Hernández-Morante, JJ, Milagro, F, Gabaldón, JA et al. (2006) Effect of DHEA-sulfate on adiponectin gene expression in adipose tissue from different fat depots in morbidly obese humans. Eur J Endocrinol 155, 593–600.
52.Villaret, A, Galitzky, J, Decaunes, P et al. (2010) Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes 59, 2755–2763.